Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Share Price
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.39 CNY | +1.19% |
|
-0.79% | -20.63% |
| Capitalization | 24TCr 3.46TCr 2.98TCr 2.79TCr 2.6TCr 4.8TCr 3,11600Cr 5.22TCr 33TCr 13TCr 1,47200Cr 13TCr 13TCr 5,38100Cr | P/E ratio 2025 * |
25.6x | P/E ratio 2026 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise value | 22TCr 3.18TCr 2.73TCr 2.56TCr 2.39TCr 4.41TCr 2,86100Cr 4.79TCr 30TCr 12TCr 1,35100Cr 12TCr 12TCr 4,94000Cr | EV / Sales 2025 * |
6.55x | EV / Sales 2026 * | 5.62x |
| Free-Float |
42.59% | Yield 2025 * |
2.6% | Yield 2026 * | 3.01% |
| 1 day | +1.19% | ||
| 1 week | -0.79% | ||
| Current month | -0.79% | ||
| 1 month | -1.92% | ||
| 3 months | -14.95% | ||
| 6 months | -12.95% | ||
| Current year | -20.63% |
| 1 week | 198.31 | 204 | |
| 1 month | 191.78 | 210.88 | |
| Current year | 191.78 | 267.1 | |
| 1 year | 191.78 | 270.71 | |
| 3 years | 191.78 | 353 | |
| 5 years | 191.78 | 503.51 | |
| 10 years | 58.56 | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 53 | 17/11/2020 |
Yun Zhao
DFI | Director of Finance/CFO | 42 | 15/11/2019 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 62 | 27/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 63 | 25/01/1999 |
Xi Ting Li
CHM | Chairman | 74 | 18/12/2001 |
Ming He Cheng
BRD | Director/Board Member | 64 | 05/01/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.19% | -0.79% | -22.99% | -37.74% | 3.46TCr | ||
| -0.43% | -3.06% | +8.20% | +4.04% | 22TCr | ||
| +1.18% | +0.32% | +4.53% | +116.04% | 20TCr | ||
| -0.39% | -0.23% | -1.68% | -14.74% | 16TCr | ||
| -0.20% | -4.00% | +8.27% | +115.94% | 14TCr | ||
| +1.92% | +1.56% | -15.42% | -11.65% | 5.65TCr | ||
| +0.48% | -0.55% | +20.49% | +19.26% | 5TCr | ||
| -1.91% | -5.22% | +3.49% | -3.87% | 4.12TCr | ||
| +3.56% | +6.84% | +5.19% | - | 3.89TCr | ||
| +2.00% | +0.28% | +6.27% | +17.83% | 3.74TCr | ||
| Average | +0.74% | -0.37% | +1.64% | +22.79% | 9.82TCr | |
| Weighted average by Cap. | +0.37% | -1.09% | +3.62% | +40.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.43TCr 485.65Cr 417.46Cr 391.07Cr 364.51Cr 673.26Cr 44TCr 732.31Cr 4.57TCr 1.77TCr 21TCr 1.82TCr 1.78TCr 75TCr | 3.92TCr 554.22Cr 476.41Cr 446.29Cr 415.97Cr 768.32Cr 50TCr 835.71Cr 5.22TCr 2.02TCr 24TCr 2.08TCr 2.04TCr 86TCr |
| Net income | 959.09Cr 135.66Cr 116.61Cr 109.24Cr 101.82Cr 188.06Cr 12TCr 204.56Cr 1.28TCr 493.36Cr 5.77TCr 509.15Cr 498.29Cr 21TCr | 1.15TCr 162.13Cr 139.36Cr 130.55Cr 121.68Cr 224.76Cr 15TCr 244.47Cr 1.53TCr 589.62Cr 6.89TCr 608.49Cr 595.5Cr 25TCr |
| Net Debt | -2TCr -283.27Cr -243.5Cr -228.11Cr -212.61Cr -392.7Cr -25TCr -427.15Cr -2.67TCr -1.03TCr -12TCr -1.06TCr -1.04TCr -44TCr | -2.47TCr -349.14Cr -300.12Cr -281.15Cr -262.05Cr -484.02Cr -31TCr -526.48Cr -3.29TCr -1.27TCr -15TCr -1.31TCr -1.28TCr -54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 202.39 ¥ | +1.19% | 44,73,259 |
| 04/25/04 | 200.00 ¥ | +0.25% | 36,31,202 |
| 03/25/03 | 199.50 ¥ | -0.56% | 44,68,966 |
| 02/25/02 | 200.62 ¥ | -0.50% | 42,51,796 |
| 01/25/01 | 201.62 ¥ | -1.17% | 58,86,038 |
End-of-day quote Shenzhen S.E., December 05, 2025
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















